Swedish Orphan Biovitrum AB (publ) (Sobi) (STO:SOBI) is pleased to announce that Canada's Drug Agency (CDA) has issued a positive reimbursement recommendation ...

Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) is pleased to announce that Canada’s Drug Agency (CDA) has issued a positive reimbursement recommendation with conditions for PrEMPAVELI ® ...

Building on recent successes, scientists are focused on a promising new frontier: sending tiny particles into the body to ...

Vaccinating against HIV has been a decades-long effort, stymied by the virus’s high mutation rate and mask of human glycans.

New research has uncovered a hidden pathway that allows COVID-19 to infect the immune system and trigger damaging ...

Understanding inflammation—and, above all, how to regulate it—is one of the great medical challenges of modern medicine. Its ...

Chronic and viral infections can literally exhaust certain key cells in the immune system from a constant barrage of attacks.

While the search for novel therapeutics remains essential, researchers are placing greater emphasis on understanding how the ...

Cemdisiran, a potential new drug for the treatment of generalized myasthenia gravis, has been accepted for priority review by ...

Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative therapies for the treatment of immune complement-related conditions and ...

Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative therapies for the treatment of immune complement-related conditions and ...

Our immune system works around the clock to protect us from bacteria, viruses, and other harmful germs. It also helps repair damaged tissues after injuries. One of its most important defense tools is ...